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Proper localization of proteins to target membranes is a fundamen-
tal cellular process. How the nature and dynamics of the targeting
complex help guide substrate proteins to the target membrane is
not understood for most pathways. Here, we address this question
for the conserved ATPase guided entry of tail-anchored protein 3
(Get3), which targets the essential class of tail-anchored proteins
(TAs) to the endoplasmic reticulum (ER). Single-molecule fluores-
cence spectroscopy showed that, contrary to previous models of a
static closed Get3•TA complex, Get3 samples open conformations on
the submillisecond timescale upon TA binding, generating a fluctuat-
ing “protean clamp” that stably traps the substrate. Point mutations
at the ATPase site bias Get3 toward closed conformations, uncouple
TA binding from induced Get3•Get4/5 disassembly, and inhibit the
ER targeting of the Get3•TA complex. These results demonstrate
an essential role of substrate-induced Get3 dynamics in driving TA
targeting to the membrane, and reveal a tightly coupled channel
of communication between the TA-binding site, ATPase site, and
effector interaction surfaces of Get3. Our results provide a prece-
dent for large-scale dynamics in a substrate-bound chaperone,
which provides an effective mechanism to retain substrate pro-
teins with high affinity while also generating functional switches
to drive vectorial cellular processes.
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Over 35% of proteins need to be localized to the correctcellular destinations after their initial synthesis in the cy-
tosol. These protein-targeting processes are essential for the
establishment and maintenance of compartmentalization in all
cells and pose complex mechanistic challenges to targeting ma-
chineries. To minimize improper exposure of substrate proteins
in the cytosol, targeting factors must bind substrate proteins with
high stability. This requirement is especially stringent during the
targeting of integral membrane proteins, whose high aggregation
propensity in the cytosol and other aqueous cellular environ-
ments demands that targeting factors also serve as effective
chaperones to protect substrates from aggregation. Further, to
minimize futile cycling of targeting factors, loading of substrates
on the targeting factor must be tightly coupled to their delivery
to membrane receptor sites. Finally, once at the target mem-
brane, the targeting machinery must readily switch to a low-
affinity state to release substrate proteins to receptor complexes,
translocases, or the phospholipid bilayer. With a few exceptions
(1, 2), the nature and dynamics of protein targeting complexes
and how their biophysical properties help meet these complex
functional demands are not well understood, especially for post-
translational protein targeting pathways.
The targeting of tail-anchored proteins (TAs) provides an
excellent system to address these questions. TAs, defined by a
single transmembrane domain (TMD) near the C terminus,
comprise up to 5% of the eukaryotic membrane proteome and
mediate diverse key cellular functions, including protein trans-
location across multiple organelle membranes, vesicular fusion,
protein quality control, and apoptosis (3). In eukaryotic cells,
TAs are targeted to the endoplasmic reticulum (ER) by the
conserved guided entry of tail-anchored protein (GET) pathway,
in which the Get3 ATPase captures TAs with help of the cyto-
solic Get4/5 complex and then delivers TAs to the Get1/2 re-
ceptor complex at the ER membrane (4–6). During the targeting
cycle, Get3 undergoes extensive changes in conformation and
activity in response to nucleotides, effector proteins, and the TA
substrate (Fig. 1A). In the cytosol, ATP binding drives the Get3
homodimer from an open conformation, in which the helical
domains of the two Get3 subunits are apart, to a closed con-
formation in which the helical domains are close together (7, 8)
(Fig. 1B). Closed ATP•Get3 is preferentially bound by the Get4/5
complex (9, 10), which bridges between Get3 and the upstream
cochaperone Sgt2 and stimulates TA transfer from Sgt2 onto Get3
(11–13). After dissociation from Get4/5, the Get3•TA complex
hydrolyzes ATP and interacts with the Get1/2 membrane receptors
(10, 14). Get1 drives Get3 into an open conformation, enabling TA
release and insertion into the membrane (11, 15–17).
Despite these advances, the conformation and dynamics of the
Get3•TA complex during targeting remain an outstanding
question (5, 6, 18). Crystallographic analyses showed that Get3
“closing” generates a contiguous hydrophobic groove in its he-
lical domains (7, 8), which provides a binding site for the TMD of TA
substrates. The cocrystal structure of Get3 bound with a TA-TMD
(13) also shows a closed Get3 similar to that in the ATP•Get3•Get4/5
complex (9). It was proposed that closed Get3 stably binds TA
substrates and protects the TMD from exposure to the cytosol (7, 13).
However, an exclusively closed Get3•TA complex poses a fundamental
dilemma for targeting (Fig. 1A, “?”). Based on thermodynamic
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coupling, if both Get4/5 and TA prefer closed Get3, TA loading
would strengthen the Get3–Get4/5 interaction. In contrast, multi-
ple downstream events in the pathway require Get3 to dissociate
from Get4/5 after TA loading. These include the interaction of
Get3 with Get1/2, whose binding sites on Get3 overlap with Get4/5
(9, 10, 15–17), and ATP hydrolysis by Get3, which is inhibited by
Get4/5 (14). These considerations predict that substrate-loaded
Get3 must adopt conformation(s) that are different from the
highly closed structures observed previously. Indeed, biochemical
studies showed that a TA substrate destabilizes the interaction of
Get3 with Get4/5 and activates the Get3 ATPase activity (10, 14),
implying that the substrate induces Get3 into distinct conforma-
tional state(s).
The GET pathway provides a salient example of the complex
functional demands on the targeting machinery during a tar-
geting cycle, as well as the conceptual and experimental chal-
lenges in understanding how these demands are met. The model
of an exclusively closed Get3•TA complex also exemplifies the
typical view of targeting complexes as static structures, wherein
substrates fit into well-defined grooves or pockets in conforma-
tionally closed targeting factors or chaperones. Recent NMR
studies began to challenge this view, demonstrating that client
Fig. 1. Direct observation of Get3 conformational changes using μs-ALEX. (A) Current model for Get3 conformations throughout the GET pathway. Question
marks (“?”) highlight unresolved questions. (B) Approximate positions of donor and acceptor dyes (green and red stars, respectively) in the structures of open
Get3 (Left; PDB ID code 3H84) and closed Get3 (Right; PDB ID code 2WOJ). The bound ADP•AlF4− in closed Get3 is in space-fill. (C–F) FRET histograms for
Get3 in apo-, ADP-, AMPPNP-, and Get1CD-bound states, respectively. Lighter shaded molecules depict alternative conformations sampled by Get3. The letter
“n” denotes the number of observed double-labeled Get3 used to generate each FRET histogram. (G–J) BVAs for apo- and ADP-, AMPPNP-, and Get1CD-
bound Get3, respectively. The red curves indicate the expected SD for shot-noise-limited E* (static limit). Triangles denote the mean SD for individual FRET
bins used to calculate the dynamic score (DS) and weighted dynamic score (WDS) (SI Materials and Methods).
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proteins populate a dynamic ensemble of conformational states
and transit between multiple short-lived interaction sites when
bound to chaperones such as Skp, SurA, and Spy during traf-
ficking through the bacterial periplasm (19–21). Nevertheless,
the nature and dynamics of the targeting factors/chaperones in
these complexes, and how these properties help guide substrate
proteins to the target membrane, have not been addressed.
To address these questions, we studied the conformation and
dynamics of Get3 using single-molecule spectroscopy with microsec-
ond time resolution. These analyses show that, contrary to previous
models, the TA substrate destabilizes a closed Get3 and induces the
ATPase to sample open conformations on the submillisecond time-
scale. Biochemical analyses demonstrate that these changes in the
TA-binding domain are transmitted via the ATPase active site to
drive the dissociation of Get3 from Get4/5, and are essential for the
targeting of TA substrates to the Get1/2 receptors at the ER mem-
brane. These results provide a unifying model to explain how the TA
substrate drives the switch of Get3 from a substrate-loading mode to
a membrane-targeting mode. Moreover, they demonstrate how rapid
protein motions allow a targeting factor/chaperone to stably retain its
substrate protein while undergoing changes in structure and function
to vectorially drive a cellular pathway.
Results
Diffusion-Based Single-Molecule Spectroscopy Detects Global Structure
and Dynamics of Get3. To measure the global conformational
changes of Get3, we used diffusion-based single-molecule Förster
resonance energy transfer (FRET) between donor (Cy3B) and
acceptor (ATTO 647N) dyes site-specifically incorporated in the
two subunits of the Get3 dimer (Fig. 1B). Fluorophores were in-
corporated at a nonconserved loop in the Get3 helical domain,
and labeling does not affect the activity of Get3 (12). We used
confocal microscopy with alternating laser excitation with micro-
second time resolution (μs-ALEX) to detect and quantify the fluo-
rescence of single molecules transiting through a femtoliter-scale
observation volume, and extracted relative FRET efficiencies (E*)
for individual molecules (22) (Fig. S1 A–C). The distances between
the dye pair are estimated to be ∼75 Å and ∼30 Å in open and closed
Get3, respectively (Fig. 1B). Hence, a significant difference in FRET
between the open and closed conformations of Get3 is expected for
this dye pair, allowing us to monitor transitions along these states.
We first used μs-ALEX to visualize the conformations of
Get3 under well-established conditions. Apo-Get3 displayed a
broad FRET distribution, with E* maxima ranging from 0.5–0.7
(Fig. 1C and reproducibility of data in Fig. S2). The distribution
for ADP-bound Get3 was also broad but peaked at higher FRET
(Fig. 1D). When Get3 was bound to the nonhydrolyzable ATP
analog adenosine 5′-(β,γ-imido)triphosphate (AMPPNP), the
FRET distribution was narrower and peaked at an E* of ∼0.8
(Fig. 1E). In contrast, the cytosolic domain of Get1 (Get1CD)
shifted the distribution to lower FRET (peak E* of ∼0.3; Fig.
1F). These data agree with previous work showing that ATP
induces Get3 to closed conformations (7, 8), whereas Get1CD
induces the open state of Get3 (15–17). To exclude photophysical
artifacts, we repeated these measurements using another FRET
pair, ATTO 550 and ATTO 647N, which yielded the same nucleotide-
and Get1CD-induced changes in FRET distributions (Fig. S3 A–
D). In addition, the presence of various ligands and interaction
partners did not affect the dye photophysics in a way that would
alter the FRET distributions (Fig. S3 E–G). We also confirmed
that Get3 dimers do not exchange subunits during measurements
(Fig. S1D and E). Thus, our labeling strategy coupled with μs-ALEX
can monitor the conformational transitions of Get3.
The FRET distributions of Get3 are broad, suggesting con-
formational heterogeneity. To distinguish whether this arises from
the coexistence of multiple static structures or from dynamic con-
formational sampling, we performed burst variance analysis (BVA),
which detects dynamics by comparing the SD of E* over time with
the SD expected from shot noise (23). If the FRET distribution
arises solely from static species, the SD is limited by shot noise and
would lie on the static limit curve (Fig. 1G–J, red lines). In contrast,
if multiple conformations interconvert on the submillisecond or
faster timescale, the observed SD would be higher than the static
limit. Apo- and ADP-bound Get3 displayed substantially higher
SDs than the static limit, especially for molecules that exhibit in-
termediate E* values (Fig. 1 G and H). In contrast, the SDs for
AMPPNP- and Get1CD-bound Get3 are close to the static limit,
especially for molecules at the peak E* values (Fig. 1 I and J).
Thus, apo-Get3 and ADP-bound Get3 sample a range of confor-
mations on the submillisecond timescale, as suggested by molecular
dynamics simulations (24), and the peak E* values of 0.4–0.6 exhibi-
ted by apo-Get3 arise from conformational averaging between
states with higher and lower FRET. Further, different interaction
partners lock Get3 into distinct and more defined conformations.
The TA Substrate Induces Get3 to Dynamically Open. To determine
the conformation of Get3 when bound to the TA substrate, we
assembled Get3•TA complexes by in vitro translation of Bos1, a
model GET substrate (12), in Escherichia coli lysate in the
presence of Get3 and affinity-purified Get3•TA complexes via
the 3xStrep-tag on Bos1 (12) (Fig. 2A). Get3•TA complexes
generated by this procedure were kinetically stable and highly
efficient in TA targeting and insertion into the ER membrane
(12) (Fig. 2B and Fig. S4 A and B). In μs-ALEX measurements,
AMPPNP•Get3•TA displayed a broader FRET distribution shifted
toward lower E* values compared with AMPPNP•Get3 (Fig. 2C).
The distributions shifted further to lower FRET and peaked at E*
values of ∼0.55–0.6 with ADP•Get3•TA and Get3•TA (Fig. 2 D
and E). In addition, BVA showed that, in contrast to AMPPNP•Get3,
Get3•TA complexes exhibiting intermediate E* values displayed
higher SD than the static limit in all nucleotide states (Fig. 2 F–H).
These observations indicate that Get3 also becomes more dynamic
upon TA binding, and the observed E* values of 0.4–0.6 result
from averaging of Get3•TA complexes that interconvert between
lower (<0.4) and higher (>0.6) FRET states on the submillisecond
or faster timescale. Thus, contrary to the highly closed Get3•TA
structure observed crystallographically (13), the TA substrate in-
duces Get3 to dynamically sample open conformations.
The Get3•TA complex was crystallized using a synthetic an-
tibody (sAB), which binds at similar surfaces on Get3 as does
Get4/5 (13); it also specifically recognizes ATP-bound Get3, as
does Get4/5 (9, 10, 13). Thus, a potential explanation for the
difference between the crystallographic and single-molecule
FRET data is that Get4/5 stabilizes a more closed conforma-
tion of Get3•TA, and this effect was mimicked by the sAB. We
therefore tested the effect of Get4/5 on Get3 conformation using
μs-ALEX. With apo-Get3, to which Get4/5 binds at a different
surface than ATP•Get3 (25), Get4/5 did not significantly change
the FRET histogram (Fig. 3A and Fig. S5G). With ADP•Get3,
which is distributed between low and high FRET states, Get4/5
shifted the distribution to predominantly high E* values (Fig. 3B
and Fig. S5G). With AMPPNP•Get3, which is already closed, Get4/5
induced a modest but statistically significant shift of the FRET
distribution to a distinct high-FRET state (Fig. 3C and Fig. S5G).
These results agree well with previous work showing that Get4/5
preferentially binds closed Get3 (9, 10). Importantly, binding of
Get4/5 also shifted the distribution of ATP•Get3•TA to higher
E* (Fig. 3D, bars vs. orange outline). Compared with the FRET
distribution of AMPPNP•Get3•Get4/5 before TA loading, the dis-
tribution after TA loading peaked at the same E* value but was
substantially broader (Fig. 3D, bars vs. teal outline). Thus, Get4/5
also biases Get3•TA to more closed conformations. Moreover,
these data illustrate sequential changes in the conformation and
dynamics of Get3 during the targeting pathway (Fig. 3E): Starting
with a static, closed AMPPNP•Get3•Get4/5 complex (black), TA loading
induces conformational “breathing” of Get3 (light orange); upon
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dissociation from Get4/5, Get3 more frequently samples open
conformations (teal) that become more dominant after ATP hy-
drolysis (dark orange).
TA Is Stably Bound by the Dynamically Fluctuating Get3. The dynamic
opening of the Get3•TA complex is unexpected, as crystallographic
analyses suggested that in open Get3, the hydrophobic groove for
TMD binding becomes discontiguous (7, 26). Intriguingly, our recent
(12) and current measurements showed that Get3•TA complexes
exhibit high kinetic stability: Using a membrane protein chaperone,
cpSRP43 (27, 28), as an inert TA trap, the timescale for sponta-
neous dissociation of Bos1 from Get3 was measured to be ∼4 h
(Fig. S4B). The lower limit for the lifetime of other Get3•TA com-
plexes was 35–60 min (12). Thus, TAs are stably bound to Get3
despite the large-scale conformational fluctuations of Get3.
The simplest modification of the current model to explain
these observations is that a 15-aa sequence termed helix α8,
which was unresolved in most Get3 structures and proposed to
Fig. 2. The TA substrate induces Get3 to dynami-
cally sample open conformations. (A) Scheme for
generation and purification of Get3•TA complexes
for μs-ALEX experiments. Green and red asterisks
denote donor and acceptor dyes labeled on Get3. A
100-fold excess of unlabeled Get3 was included to
ensure that, statistically, intradimer FRET of Get3
was measured even in cases of potential Get3 tet-
ramerization (8, 10, 14). Experimental details are
provided in Materials and Methods. IVT, in vitro
translation. (B) Get3•TA complexes prepared using
the procedure in A are active in targeting and in-
sertion into the ER. Representative SDS/PAGE auto-
radiograph (Top) and its quantification (Bottom) for
the time courses of Get3•TA targeting and insertion
are shown for wild-type Get3 (black solid line) and
mutant Get3(Δα8) (cyan). The dotted curve depicts
the insertion efficiency for Get3•TA generated with
Sgt2 and Get4/5 included during translation as de-
scribed previously (12), and shows that the inclusion
of Sgt2 and Get4/5 is not necessary for generation of
a functional Get3•TA complex. glyc, glycosylated;
yRM, yeast rough microsome. (C–E) FRET histograms
of Get3•TA complexes in AMPPNP-bound, ADP-bound,
and nucleotide-free states, respectively. The outlines
depict the FRET histograms of Get3 in the same nu-
cleotide state without TA substrate and are shown
for comparison; “n” denotes the number of observed
double-labeled Get3 used to generate each FRET his-
togram. (F–H) BVAs of Get3•TA in AMPPNP-bound,
ADP-bound, and nucleotide-free states, respectively.
The red curves represent the SD expected for shot-
noise-limited E*. Triangles denote the mean SD for in-
dividual FRET bins used to calculate the dynamic score
(DS) and weighted dynamic score (WDS).
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form a lid over the TA-binding groove (7, 13), could prevent the
escape of TA substrates during opening. Nevertheless, a structure
of apo-Get3 [Protein Data Bank (PDB) ID code 3A36], in which
α8 was resolved (29), suggests that the dimension of α8 is unlikely
to be sufficient to completely shield the helical domains and block
TA escape in open Get3 (Fig. S4C, α8 highlighted in cyan). To ex-
perimentally test the importance of α8, we replaced the conserved
hydrophobic residues (199PMLNSFM) in this sequence with a GS
linker (GGSGGGS) to generate mutant Get3(Δα8). Get3•TA
complexes assembled with mutant Get3(Δα8) could be purified as
a stable complex (Fig. S4D) and are fully functional in TA tar-
geting and insertion into the ER membrane (Fig. 2B, cyan curve).
These results show that shielding by α8 is insufficient to explain the
high stability of the Get3•TA complex if the current model of
Get3–TA interaction were the only possible interaction mode.
Following the principle of thermodynamic coupling, the observa-
tion of TA-induced Get3 opening further predicts that the TA
substrate can explore alternative modes for interacting with a more
open Get3 that are energetically more favorable than the estab-
lished interaction mode observed with closed Get3 (Fig. S4E). The
implications of these observations are elaborated in Discussion.
TA-Induced Get3 Opening Drives Membrane Targeting. At the junc-
tion of the Get3 helical and ATPase domains is a network of
residues that interact across the dimer interface and contribute
catalytic interactions with ATP (7, 8, 26, 29) (Fig. S6A), raising
the possibility that disruption of this network would interfere
with the ability of Get3 to undergo regulated conformational
changes. We tested two mutations in this network, D57N and
E251A, which cause severe yeast growth defects under stress
conditions (7, 26). Both mutants bind ATP tightly but displayed
102-fold slower ATPase activity than wild-type Get3 (7) (Fig. S6
C–F). Surprisingly, μs-ALEX measurements showed that these
mutations bias Get3 toward closed conformations under differ-
ent conditions. Get3(E251A) is more closed than Get3(WT)
when bound with nucleotides (Fig. 4 A–D), whereas Get3(D57N)
is more closed than Get3(WT) in apo- and Get1CD-bound states
(Fig. 4 G–J). In the Get3•TA complex, the FRET distributions
of mutant Get3(D57N) were shifted to higher E* with and
without ATP and Get4/5 present (Fig. 4 K and L), whereas only
the FRET distribution of free Get3(E251A)•TA was shifted
(Fig. 4 E and F). Although the mutational effects on the FRET
distributions of Get3•TA were modest, the changes are sys-
tematic compared with variations between replicates of data and
are statistically significant (Figs. S2 and S5). The different effects
of the two mutations on the FRET distributions of Get3•TA also
agreed well with biochemical analyses of these mutants described
later (see Fig. 6). Thus, point mutations at the Get3 catalytic site
alter the conformation and regulation of its helical domains.
To assess if the conformational bias in Get3(D57N) and Get3
(E251A) disrupts Get3 function, we tested the activities of these
mutants in mediating TA targeting and insertion into the ER
membrane. Without Get4/5 present, Get3(D57N)•TA and Get3
(E251A)•TA were up to threefold and fivefold slower, re-
spectively, than wild-type Get3•TA in targeting and insertion
(Fig. 5 A, C, and E). However, physiological amounts of Get4/5
(30) nearly abolished TA insertion with both mutants, without
substantially affecting TA insertion by wild-type Get3 (Fig. 5 B,
D, and F). These mutational defects were observed regardless of
the nucleotide state of Get3•TA complexes (Fig. 5 A–F); the
slower phase of the insertion reactions with apo-Get3 was due to
the nucleotide requirement for recycling Get3 from the ER
membrane during multiple rounds of TA targeting (10, 11, 16).
Together, these results show that TA-induced Get3 opening is es-
sential for membrane targeting of the Get3•TA complex under
conditions that mimic the physiological situation, where the Get1/2
receptor and Get4/5 complex must compete for binding to Get3.
The following data indicate that the effects of these Get3
mutants did not arise solely from the failure to hydrolyze ATP,
but rather from defects in undergoing TA-induced conforma-
tional changes. Even with AMPPNP bound, targeting and in-
sertion from wild-type Get3•TA was efficient (compare black
lines in Fig. 5 A vs. G); thus, ATP hydrolysis per se is not re-
quired for membrane targeting (8). Wild-type AMPPNP•Get3•TA
Fig. 3. Sequential opening of Get3 upon TA loading and Get4/5 release. (A–
C) Effects of Get4/5 on the FRET histograms of apo-, ADP-, and AMPPNP-
bound Get3, respectively. (D) FRET histogram of Get3•TA bound with Get4/5
and ATP. The complex was generated by supplementing Get4/5 and excess ATP
throughout the preparation to capture the conformation of the physiological
initial loading complex (Materials and Methods). Since Get4/5 inhibits ATP hy-
drolysis (14) and excess ATP is used, ATP turnover has no significant effect on the
results. (E) Comparisons of FRET histograms of Get3 at different stages of the
GET pathway. In A–D, the outlines depict the FRET histograms of indicated
Get3 complexes and are shown for comparison, and “n” denotes the number of
observed double-labeled Get3 used to generate each FRET histogram.
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also tolerated the presence of Get4/5 and allowed TA insertion
(Fig. 5G, purple), albeit three- to fivefold more slowly than
the reaction of ATP•Get3•TA with Get4/5 present (Fig. 5B,
black). Thus, ATP hydrolysis contributes three- to fivefold, but is not
obligatory for the exchange of Get4/5 with Get1/2 on the Get3•TA
complex. Further, the ATP occupancy of Get3(D57N)•TA and
Get3(E251A)•TA complexes was measured to be 39% and 5.8%,
respectively (Fig. S7D); even if only the ADP- or nucleotide-free
targeting complexes were active, these ATP occupancies predict
that the two mutants would retain 61% and 94%, respectively, of
the targeting activity of wild-type Get3, which were insufficient
to explain their targeting defects. Finally, the Get4/5-specific
targeting defect of both Get3 mutants was observed regardless
of the added nucleotide (Fig. 5 A–F). Assuming the simplest
model in which the observed insertion occurs from the fraction
of Get3•TA complexes that acquired a targeting-competent con-
formation, the biochemical data suggested that the defect of
mutant Get3(E251A)•TA in attaining the active conformation
was ∼70-fold after ATP hydrolysis [Fig. 5D, compare the time
required for 11% insertion with ADP•Get3•TA vs. ADP•Get3
(E251A)•TA]. These results underscore the essential role of
TA-induced Get3 conformational change in driving membrane
targeting.
The Get3 Active Site Couples the TA-Binding Site to the Get3–Effector
Interaction Surface. The Get4/5-specific targeting defects of Get3
(D57N) and Get3(E251A) suggest that these mutants fail to
dissociate from Get4/5 after TA loading, and thus block the
subsequent interaction of Get3 with the Get1/2 receptor complex
at the ER membrane. To test this hypothesis, we measured the
Get3–Get4/5 interaction using an established assay based on the
fluorescence enhancement of acrylodan labeled at Get4(S48C/
C177T) upon Get3 binding (10). Equilibrium titrations showed
that while wild-type Get3•TA bound Get4/5 much more weakly than
ATP•Get3, as observed previously (10), mutant Get3(D57N)•TA and
Get3(E251A)•TA retained high-affinity binding to Get4/5 (Fig.
6 A and B, Fig. S8 A–C, and Table S1). Thus, small defects in
Get3 opening (Fig. 4 E, F, K, and L) could severely block the
TA-induced disassembly of the Get3•Get4/5 complex.
How do TAs induce the dissociation of Get3 from Get4/5?
Structural work showed that Get4 contacts ATP-bound Get3 at two
interfaces: an anchoring interface, which enables stable binding, and a
regulatory interface, which regulates Get3’s ATPase activity (9) (Fig.
S6B). We introduced the Get4(D74K) mutation that disrupts the salt
bridge between Get4-D74 and Get3-K69 at the regulatory interface
(9) (Fig. 6C). The affinity of Get3 for wild-type Get4/5 relative
to mutant Get4(D74K)/5 provides a measure for the energetic
contribution of this salt bridge to Get3-Get4/5 binding. While the
Fig. 4. Point mutations at the ATPase active site
bias Get3 to more closed conformations. (A–D) FRET
histograms of Get3(E251A) in apo- and AMPPNP-,
ADP-, and Get1CD-bound states, respectively. (E and
F) FRET histograms of Get3(E251A)•TA without (E)
or with (F) Get4/5 and ATP bound. (G–J) FRET histo-
grams of Get3(D57N) in apo- and AMPPNP-, ADP-,
and Get1CD-bound states, respectively. (K and L)
FRET histograms of Get3(D57N)•TA without (K) and
with (L) Get4/5 and ATP bound. In all histograms, the
orange outlines depict the FRET histograms of wild-
type Get3 under the same conditions, and “n” denotes
the number of observed double-labeled molecules
used to generate each FRET histogram.
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Get4(D74K) mutation weakened the binding to ATP•Get3 fivefold
(9), the mutational effect was >20-fold with AMPPNP•Get3•TA
and then became negligible with Get3•TA (Fig. 6D, black bars
and Table S1). These results illustrate sequential changes at the
Get3–Get4 regulatory interface, where the Get3(K69)-Get4(D74)
salt bridge is ancillary before TA binding, becomes stronger upon
TA loading, and then dissolves after nucleotide hydrolysis and
release from Get3•TA.
Importantly, while the TA substrate failed to weaken the
binding of Get3(D57N) and Get3(E251A) with wild-type Get4/5
(Fig. 6B), it did with mutant Get4(D74K)/5 (Fig. 6E and Fig. S8
D and E), suggesting that the Get3 active site mutants exert their
effects by blocking changes at the Get3–Get4 regulatory inter-
face. Analysis of the mutational effects of Get4(D74K) on the Get3
active site mutants further showed that Get3(E251A) is primarily
defective in removing the Get3-Get4 contact at the regulatory in-
terface after nucleotide hydrolysis and release, while Get3(D57N) is
defective in rearranging this interface both before and after ATP
hydrolysis (Fig. 6D, red and blue bars and Table S1). These data
agreed well with the different effects of these mutations on the
FRET distributions of Get3•TA and ATP•Get3•TA (Fig. 4 E and
F vs. K and L), and together they showed that the catalytic res-
idues at the Get3 active site provide key functional links between
the TA-binding site and the Get4/5 interaction surface of Get3.
Finally, the Get4(D74K) mutation abolished the inhibitory effect
of Get4/5 on the targeting of Get3(D57N)•TA (Fig. 6F) and
wild-type AMPPNP•Get3•TA (Fig. 5G), indicating that the TA-
induced rearrangements at the Get3–Get4 regulatory interface
directly impact targeting efficiency.
Fig. 5. Get3 active site mutants block the targeting of Get3•TA complexes.
Time courses for targeting and insertion of wild-type and mutant Get3•TA
complexes in the absence (A, C, and E) and presence (B, D, and F) of 0.5 μM
Get4/5. The nucleotides used in the insertion reactions are as follows: 2 mM
ATP in A and B, 2 mM ADP in C and D, and no nucleotides in E and F. (G) Time
courses for targeting and insertion of wild-type AMPPNP•Get3•TA with and
without Get4/5 or mutant Get4(D74K)/5 present. All experiments were re-
peated on different days (n ≥ 2) and are plotted as mean ± SD. yRM, yeast
rough microsome.
Fig. 6. The TA substrate regulates the Get3–Get4 interaction. (A and B)
Representative equilibrium titrations to measure the binding of Get4/5 to
wild-type and mutant Get3 in the ATP-bound (A) and TA-bound (B) states.
arb., arbitrary. (C) Get3-K69 forms a putative salt bridge (dotted line) with
Get4-D74 at the regulatory interface (PDB ID code 4PWX). Mutation of Get3-
K69 or Get4-D74 did not substantially reduce Get3-Get4/5 binding but dis-
rupted the ability of Get4/5 to regulate ATP hydrolysis by Get3 (9). (D)
Summary of the effects of the Get4(D74K) mutation on the binding affinity of
Get4/5 for wild-type and mutant Get3 (Kbinding = 1/Kd) in the indicated com-
plexes. Data are from Table S1 and are reported as mean ± propagated
error, with n ≥ 2. (E ) Representative equilibrium titrations to measure
the binding of Get4(D74K)/5 to wild-type and mutant Get3•TA complexes.
Dashed lines are the binding curves of wild-type Get4/5 to the corre-
sponding Get3 variant (from B) and are shown for comparison. (F ) Time
courses for targeting and insertion of Get3(D57N)•TA in the presence of
ATP and indicated Get4/5 variants (n = 2).
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Discussion
Across all organisms, targeting complexes guide nascent pro-
teins to diverse cellular destinations. These complexes must
bind substrate proteins with high overall stability, while also
readily switching structure and function to drive these vectorial
processes. In this work, single-molecule fluorescence spectros-
copy coupled with biochemical analyses provide a unifying
model to explain how these complex demands are met during TA
targeting by the Get3 ATPase. In contrast to previous models, TA
loading destablizes a static, closed Get3•TA complex and induces
Get3 to rapidly sample open conformations, and TA substrates are
stably trapped in the rapidly fluctuating Get3. Point mutations at
the ATPase active site bias Get3 toward closed conformations,
uncouple TA binding from substrate-induced Get3•Get4/5 disas-
sembly, and inhibit the targeting of the Get3•TA complex to the
ER membrane. These data demonstrate how the substrate-induced
dynamic opening of Get3 provides a dual mechanism that allows
the targeting complex to both retain substrates with high affinity
and drive the exchange of Get3’s interaction partners required for
the ER targeting of TAs.
The substrate-induced opening of Get3 is unexpected, given
the large and contiguous hydrophobic groove in closed Get3 that
appears highly conducive to TA binding (7, 8, 13) as well as the
high kinetic stability of Get3•TA complexes (12) (Fig. S4B). The
TA-induced opening of Get3 further suggests that the TA sub-
strate explores alternative sites and conformations for interacting
with Get3 besides the previously observed docking of the TA-
TMD at the well-defined hydrophobic groove in closed Get3,
and that, collectively, these alternative Get3–TA interaction
modes are energetically more favorable than the established
mode. In analogy to membrane protein substrates bound to the
Skp and SurA chaperones (19, 20), it is plausible that TA sub-
strates sample multiple transient interaction sites during Get3
opening, and TAs could be retained because interaction with
alternative sites in Get3 is more favorable than with solvent. This
model would explain, in part, the weak electron density for TA-
TMDs in previous Get3•TA structures (13). Alternatively or in
addition, the rapid conformational fluctuations of Get3 could
enable its reclosing to kinetically outcompete potential TA dis-
sociation from the targeting complex during Get3 opening. Po-
tential tetramerization of Get3 upon TA binding (8, 14) could
provide another mechanism to retain substrate in a more open
Get3; as a recent study did not detect stable tetrameric Get3•TA
complexes and showed that dimeric Get3•TA is active in medi-
ating TA insertion (13), the precise roles of Get3 tetramerization
remain to be determined. Finally, increased conformational entropy
in these more dynamic models could contribute to the overall sta-
bility of the targeting complex. Regardless of the specific mechanism
of substrate retention, our results collectively show that substrate
proteins can be stably bound to a targeting factor/chaperone while
the latter undergoes large-scale fluctuations between open and
closed states.
The targeting pathway demands extensive changes in the activ-
ities of Get3 before and after substrate loading. Before TA bind-
ing, Get3 must be ATP-bound and tightly bound to Get4/5,
whereas after TA loading, Get3 must hydrolyze ATP and detach
from Get4/5 so that it can instead interact with the Get1/2 recep-
tors at the ER membrane. The results from this and previous work
(9, 10, 14) demonstrate that nucleotide, together with the Get4/5
complex, is responsible for inducing a highly closed conformation
of Get3. Although these results provide an attractive mechanism to
explain how Get3 efficiently captures TA substrates at early stages
of the pathway, they fail to explain the functional switches of Get3
required for the targeting phase of the pathway. The substrate-
induced opening of Get3 provides an attractive mechanism to
drive this functional switch, and thus resolves this dilemma.
Experimentally, the important role of substrate-induced Get3
opening is demonstrated by the D57N and E251A mutations at
the Get3 ATPase site, both of which bias Get3 toward closed
conformations. These mutants uncouple TA binding from TA-
induced changes in Get3’s biochemical activities, including dis-
sociation from Get4/5 and efficient targeting of TA substrates to
the ER membrane. Although the targeting defect of Get3
(D57N) was previously attributed to failed ATP hydrolysis (7, 11,
16), complete analysis of the targeting reaction in all nucleotide
states, including the nonhydrolyzable ATP analog AMPPNP,
showed that the targeting defects of Get3 active site mutants are
largely conformational in origin (Fig. 7, step 5). The majority of
the defects of Get3(D57N) and Get3(E251A) can be attributed
to their failures to undergo TA-induced dissociation from Get4/5,
which competes with the Get1/2 receptors for binding Get3. In
addition, the three- to sixfold defects of these mutants in ER
targeting in the absence of Get4/5 suggest that TA-induced
Get3 opening facilitates the binding and remodeling of the
targeting complex by Get1/2. By combining these mutants with
disruptions at the Get3–Get4 regulatory interface, we further
demonstrate sequential TA-induced adjustments at the Get3–
Get4 interaction surface that drive their disassembly, and how
Get3 active site mutations disrupt this relay of signal. Together,
these data reveal a tightly coupled channel of communication
between the TA-binding site, ATPase catalytic site, and effec-
tor interaction surfaces on Get3.
Collectively, our results illustrate how substrate-induced dy-
namic opening switches Get3 from a TA-loading mode to a
targeting mode, thus initiating downstream steps in the GET
pathway (Fig. 7). At early stages, ATP and Get4/5 lock Get3 into
an occluded conformation, in which Get3 is closed and ATPase-
inhibited (9, 14), and thus primed for TA capture (step 1). The
closed Get3•TA-TMD structure, obtained with mutant Get3(D57N)
and an sABmimicking the interaction sites and biochemical activities
of Get4/5 (13), likely represents the initial ATP•Get3•TA•Get4/5
complex. TA loading destabilizes this static structure and induces
Get3 to undergo rapid conformational fluctuations to explore the
more open state (step 2). These changes in the TA-binding domain
are transmitted via the Get3 catalytic site to induce rearrangements
at the Get3–Get4 interface, shifting stabilizing interactions from the
anchoring interface to the regulatory interface (step 2). At this stage,
spontaneous Get4/5 dissociation from Get3 (step 3), which is rapid
despite the high stability of the complex (10), allows Get3•TA to
further open and enables TA-induced ATPase activation (step 4).
Opening of Get3 becomes more extensive after ATP hydrolysis
(step 5), rendering the dissociation of Get4/5 irreversible and
priming Get3 for interaction with the Get1/2 receptors instead (step
6). In addition, dynamic opening of the Get3•TA complex could
provide a facile pathway for its remodeling by the Get1/2 receptor
complex, facilitating TA release and insertion into the ER mem-
brane (step 6); this may explain the modest but still significant
defects of the Get3 active site mutants in TA insertion in the ab-
sence of Get4/5. Importantly, while Get1 was primarily responsible
for opening Get3 in most previous models (11, 15–17), our findings
show that the TA substrate itself initiates this opening to vectorially
drive late stages of the targeting cycle.
Current models of substrate interactions with targeting factors
and molecular chaperones often fall into the category of lock-and-key
mechanisms, in which substrate proteins fit into preorganized, well-
structured grooves or pockets in the substrate-binding domain (31–
35). Although these mechanisms provide excellent explanations for
how substrate proteins are captured, they also generate thermo-
dynamic sinks that inhibit subsequent steps in the pathway, anal-
ogous to the situation described for Get3 (18). Our observations
provide a precedent for a distinct class of models, in which rapid
conformational fluctuations of a targeting factor/chaperone gen-
erate a “protean trap” that can retain substrates with high stability,
and the dynamic nature of the complex enables functional switches
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to guide progression of the pathway. Analogous protean traps may
provide an effective mechanism in other targeting factors, chaper-
ones, and transporters that need to retain substrates with high af-
finity, while driving vectorial pathways that require distinct functions
to be switched “on” and “off” in a sequential and coordinated
manner.
Materials and Methods
Plasmids. Plasmids for recombinant expression of Get3, Get4/5, Get1CD, and
a superactive mutant of the cpSRP43 chaperone (intein-cpSRP43) and for in
vitro translation of 3xStrep-SUMOnc-Bos1-opsin have been described (10,
12, 14, 28). DNA encoding 2xStrep-Sbh1 was in the pACYCDuet-1 vector.
Plasmids encoding mutant proteins were generated using QuikChange
site-directed mutagenesis (Stratagene) or FastCloning (36), and were
confirmed with DNA sequencing (Laragen).
Biochemical Reagents. Get3, Get4/5, Get1CD, and intein-cpSRP43 were
expressed and purified as described (10, 12, 14, 28). E. coli S30 lysate and T7
RNA polymerase were prepared as described (12, 37). Microsomes were
prepared from Δget3 yeast cells as described (14, 38, 39).
Get3•TA complexes for μs-ALEX and insertion assays were generated as
described (12) with modifications. For μs-ALEX, the model TA 3xStrep-Bos1-
opsin (12) was in vitro-translated in E. coli S30 lysate for 2 h at 30 °C in the
presence of 2 μM Get3 (1:100 double-labeled to unlabeled), with or without
2 μM Sgt2 and 2 μM Get4/5 present. Complexes containing 3xStrep-tagged
TA were purified using Strep-Tactin Sepharose (IBA Life Sciences) as de-
scribed (12). Omission of Sgt2 and Get4/5 in this procedure does not change
the targeting and insertion activity of Get3•TA (Fig. 2B). To characterize the
effects of Get4/5 and ATP on Get3•TA conformation (Figs. 3D and 4 F and L),
0.5 μM Get4/5 and 2 mM ATP were present throughout the purification,
and excess Get4/5 and ATP were supplemented to the purified complex.
Get3BDP•TACM complexes used in Fig. S4B were generated as described (12).
Recombinant Get3•Sbh1 complexes were purified as described (13) with
modifications. Untagged Get3 and 2xStrep-Sbh1 were coexpressed in One
Shot BL21 Star (DE3) (Invitrogen) for 6 h at 26 °C after induction with 0.1 mM
isopropyl β-D-1-thiogalactopyranoside at OD600 ∼ 0.8. Cells were disrupted by
sonication in lysis buffer [50 mM Tris·HCl (pH 7.6), 300 mM NaCl, 5 mM
β-mercaptoethanol, protease inhibitors]. Complexes containing 2xStrep-
Sbh1 were purified using Strep-Tactin Sepharose followed by Superdex 200
10/300 GL (GE Healthcare) in GET buffer [50 mM KHEPES (pH 7.4), 150 mM
KOAc, 5 mM Mg(OAc)2, 1 mM DTT, 10% glycerol] (Fig. S7 A–C).
Fluorescence Labeling. We have described a strategy to site-specifically label
Get3 at a ybbR tag inserted between residues 110 and 111 via Sfp-catalyzed
incorporation of dye-CoA conjugates; ybbR insertion and fluorescence
labeling do not perturb Get3 function (12). Using this strategy, we stochastically
double-labeled Get3 dimers with a 1:1 ratio of CoA-conjugated Cy3B-
maleimide (GE Healthcare) or ATTO 550-maleimide (ATTO-TEC) and CoA-
conjugated ATTO 647N-maleimide (ATTO-TEC) at the α4-α5 loop. Donor- or
acceptor-only Get3s were generated by labeling with one of the dyes. CoA-
conjugated BODIPY FL maleimide (Thermo Fisher Scientific) was used to gen-
erate the Get3BDP used in Fig. S4B. Get4(C177T/S48C)/5 and Get4(C177T/S48C/
D74K)/5 were labeled with acrylodan as described (10).
Biochemical Assays. Fifty-microliter TA targeting and insertion reactions were
initiated by adding 10 μL of Δget3 microsomes to purified Get3•TA com-
plexes in which [35S]-methionine–labeled TA was normalized to 40,000 dpm.
Two millimolar nucleotide and/or 0.5 μM Get4/5 was included where in-
dicated. Reactions were incubated at 26 °C; at indicated time points, 6-μL
samples were removed and quenched by addition of 2× SDS buffer and
flash-freezing in liquid nitrogen. Samples were analyzed by SDS/PAGE
and autoradiography.
Equilibrium-binding measurements between Get3 and acrylodan-labeled
Get4/5 were performed as described (10). Get3BDP•TACM dissociation experi-
ments were performed as described (12), except that indicated concentrations
of intein-cpSRP43 were used as a chase instead of unlabeled Get3 (which we
found to modestly accelerate TA dissociation). Multisite, multiturnover ATPase
rate constants for Get3 were measured as described (14). The ATP concentra-
tions in Get3 and Get3•TA samples were quantified using a luminescent ATP
detection assay kit (ab113849; Abcam) per the manufacturer’s instructions.
μs-ALEX Measurements. All proteins were ultracentrifuged in a TLA 100 rotor
(Beckman Coulter) at 100,000 rpm for 1 h at 4 °C to remove aggregates
before all measurements. Get3 samples were diluted to ∼100 pM in GET
buffer containing 0.3 mg/mL BSA and indicated interaction partners. Based
on previously determined Kd values (10, 14), saturating amounts of each
interaction partner (2 mM AMPPNP, 4 mM ADP, 10 μM Get1CD, 4 μM Get4/5)
were used to ensure that all observed Get3 molecules were ligand-bound.
Samples were placed in a closed chamber made by sandwiching a perforated
silicone sheet (Grace Bio-Labs) with two coverslips to prevent evaporation.
Data were collected over 30–60 min using an ALEX–fluorescence-aided
molecule sorting setup (40) with two single-photon Avalanche photodiodes
(PerkinElmer) and 532-nm and 638-nm continuous wave lasers (Coherent)
operating at 135 μW and 80 μW, respectively. Details of single-molecule data
analysis are described in SI Materials and Methods.
Fig. 7. Model for how TA-induced Get3 opening
drives the membrane targeting of the Get3•TA
complex. Step 1: ATP•Get3 is bound to Get4/5, which
induces Get3 to a closed, occluded conformation
that inhibits ATP hydrolysis. TA is transferred from
Sgt2 to Get3 in the Sgt2•Get4/5•Get3•TA complex,
in which Get4/5 bridges Sgt2 and Get3. Step 2:
TA loading induces Get3 to sample more open con-
formations, with concomitant adjustment at the
Get3•Get4/5 interface that causes the regulatory
interface to become the predominant stabilizing
interaction. Step 3: Get4/5 spontaneously and re-
versibly dissociates from the conformationally ad-
justed Get3•TA complex. Step 4: TA induces Get3 to
rapidly hydrolyze ATP after Get4/5 dissociation. Step
5: After ATP hydrolysis, Get3•TA becomes more
open, attaining a strained conformation that pre-
vents rebinding of Get4/5. Step 6: The strained
Get3•TA complex is primed for targeting to and
remodeling by the Get1/2 receptors at the ER
membrane. Step 7: Get1/2 facilitates TA disassembly
from Get3 and TA insertion into the membrane.
Binding of ATP and Get4/5 releases Get3 from the
membrane receptors, recycling it for additional
rounds of targeting. The inhibition marks denote
steps inhibited by the E251A and D57N mutations,
with inhibition of step 5 being responsible for the
majority of defects of these mutants on the overall
targeting reaction under physiological conditions.
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